Search Results - "Snape, Matthew"

Refine Results
  1. 1

    COVID-19 in children and young people by Snape, Matthew D, Viner, Russell M

    “…Children have a low risk of COVID-19 and are disproportionately harmed by precautions The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic…”
    Get full text
    Journal Article
  2. 2

    Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data by Shaw, Robert H, Stuart, Arabella, Greenland, Melanie, Liu, Xinxue, Nguyen Van-Tam, Jonathan S, Snape, Matthew D

    Published in The Lancet (British edition) (29-05-2021)
    “…Haematology and biochemistry safety monitoring blood results are also reported from the immunology cohort (100 participants with additional visits), at…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Preventing type 1 diabetes in childhood by Dayan, Colin M., Besser, Rachel E. J., Oram, Richard A., Hagopian, William, Vatish, Manu, Bendor-Samuel, Owen, Snape, Matthew D., Todd, John A.

    “…Type 1 diabetes (T1D) is an autoimmune disease in which the insulin-producing β cells of the pancreas are destroyed by T lymphocytes. Recent studies have…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The burden of respiratory syncytial virus in healthy term-born infants in Europe: a prospective birth cohort study by Wildenbeest, Joanne G, Billard, Marie-Noëlle, Zuurbier, Roy P, Korsten, Koos, Langedijk, Annefleur C, van de Ven, Peter M, Snape, Matthew D, Drysdale, Simon B, Pollard, Andrew J, Robinson, Hannah, Heikkinen, Terho, Cunningham, Steve, O'Neill, Thomas, Rizkalla, Bishoy, Dacosta-Urbieta, Ana, Martinón-Torres, Federico, van Houten, Marlies A, Bont, Louis J, Wildenbeest, Joanne, Billard, Marie-Noëlle, Zuurbier, Roy, Korsten, Koos, van Houten, Marlies, Langedijk, Annefleur, van de Ven, Peter, Bont, Louis, Drysdale, Simon, McGinley, Joseph, Lin, Gu-Lung, Snape, Matthew, Pollard, Andrew, Ives, Andrew, Wolfenden, Helen, Salgia, Sanjay, Shetty, Rohoth, Dacosta-Urbieta, Ana, Rivero-Calle, Irene, Gómez-Carballa, Alberto, Pischedda, Sara, Rodriguez-Tenreiro, Carmen, Martinón-Torres, Federico, Heikkinen, Terho, Cunningham, Steve, Nair, Harish, Campbell, Harry, O'Neill, Thomas, Miller, Margaret, Baggott, Julie, Beveridge, Catherine, McKernan, Rachael, Rizkalla, Bishoy, Beutels, Philippe, Openshaw, Peter, Meijer, Adam, Kølsen Fischer, Thea, van den Berge, Maarten, Giaquinto, Carlo, Abram, Michael, Swanson, Kena, Aerssens, Jeroen, Vernhes, Charlotte, Gallichan, Scott, Kumar, Veena, Molero, Eva

    Published in The lancet respiratory medicine (01-04-2023)
    “…Respiratory syncytial virus (RSV) is a major cause of hospitalisation in infants. The burden of RSV infection in healthy term infants has not yet been…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    An increase in accident and emergency presentations for adverse events following immunisation after introduction of the group B meningococcal vaccine: an observational study by Nainani, Viveka, Galal, Ushma, Buttery, Jim, Snape, Matthew D

    Published in Archives of disease in childhood (01-10-2017)
    “…ObjectivesTo determine whether the introduction of the capsular group B meningococcal vaccine (4CMenB) in the UK has increased presentations of infants to…”
    Get full text
    Journal Article
  11. 11

    Meningococcal meningitis presenting postinfant group B meningococcal immunisation by So, Neda, Pal, Rani, Snape, Matthew D

    Published in Archives of disease in childhood (01-09-2019)
    “…Correspondence to Prof Matthew D Snape, Department of Paediatrics, University of Oxford, Oxford OX3 7LJ, UK; matthew.snape@paediatrics.ox.ac.uk We report an…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Pandemic influenza A H1N1 vaccines and narcolepsy: vaccine safety surveillance in action by Barker, Charlotte I S, Dr, Snape, Matthew D, MD

    Published in The Lancet infectious diseases (01-03-2014)
    “…Summary The 2009 influenza A H1N1 pandemic placed unprecedented demand on public health authorities and the vaccine industry. Efforts were coordinated…”
    Get full text
    Journal Article
  16. 16

    Respiratory syncytial virus seasonality and its implications on prevention strategies by Janet, Sophie, Broad, Jonathan, Snape, Matthew D.

    Published in Human vaccines & immunotherapeutics (02-01-2018)
    “…With maternal and infant vaccines against respiratory syncytial virus (RSV) in development, it is timely to consider how the deployment of these vaccines might…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    The price of prevention: what now for immunisation against meningococcus B? by Moxon, Richard, Snape, Matthew D

    Published in The Lancet (British edition) (03-08-2013)
    “…[...]the JCVI acknowledges that the relative rarity of meningococcal disease had precluded any realistic possibility of a classic efficacy trial.2 This is why…”
    Get full text
    Journal Article
  20. 20

    Safety and Immunogenicity of an mRNA-Based hMPV/PIV3 Combination Vaccine in Seropositive Children by Schnyder Ghamloush, Sabine, Essink, Brandon, Hu, Bo, Kalidindi, Shiva, Morsy, Louie, Egwuenu-Dumbuya, Chioma, Kapoor, Archana, Girard, Bethany, Dhar, Rakesh, Lackey, Rebecca, Snape, Matthew D, Shaw, Christine A

    Published in Pediatrics (Evanston) (01-06-2024)
    “…Human metapneumovirus (hMPV) and parainfluenza virus type 3 (PIV3) are common respiratory illnesses in children. The safety and immunogenicity of an…”
    Get full text
    Journal Article